Abstract
We present the analysis of a prospective multicentre study to investigate genetic effects on the prognosis of newly treated epilepsy. Patients with a new clinical diagnosis of epilepsy requiring medication were recruited and followed up prospectively. The clinical outcome was defined as freedom from seizures for a minimum of 12 months in accordance with the consensus statement from the International League Against Epilepsy (ILAE). Genetic effects on remission of seizures after starting treatment were analysed with and without adjustment for significant clinical prognostic factors, and the results from each cohort were combined using a fixedeffects meta-analysis. After quality control (QC), we analysed 889 newly treated epilepsy patients using 472 450.
Original language | English |
---|---|
Article number | ddt403 |
Pages (from-to) | 247-258 |
Number of pages | 12 |
Journal | Human Molecular Genetics |
Volume | 23 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2014 |
Externally published | Yes |